Georgia D. Montouris, MD
Clinical Associate Professor
Boston University School of Medicine
Dept of Neurology

MD, Free University of Brussels




A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety to Brivaracetam in subjects (>16 to 80 years old) with partial onset seizures
06/01/2011 - 05/31/2012 (PI)
UCB Biosciences Inc.


A Phase 3, open-label, multicenter, follow-up study to evaluate the long-term safety and efficacy of Protocol #1379
06/01/2011 - 05/31/2012 (PI)
UCB Biosciences Inc.


Trileptal Pregnancy Registry
07/01/2006 - 06/30/2007 (PI)
Minnesota Epilepsy Group, P.A.

An Open-Label Extension Trial to Determine Safety and Efficacy of Long-Term Oral SPM 927 in Patients with Partial Seizures
10/06/2004 - 01/31/2007 (PI)
Schwarz Biosciences, Inc.

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-group Trial to Investigate the Efficacy and Safety of SPM 927 (400 and 600 mg/day) as Adjunctive Therapy in Subjects with Partial Seizures with or without Secondary Generalization
04/01/2004 - 03/30/2006 (PI)
Schwarz Biosciences, Inc.

A Multi-Center, Open-Label, Long-Term, Follow-Up Study of the Safety and Efficacy of Levetiracetam in Children with Partial Onset Seizures
12/13/2004 - 12/12/2005 (PI)
UCB, Inc.


A Multi-Center, Double-Blind, Randomized, Parallel-Group Evaluation of Lamictal Extended-Release Adjunctive Therapy In Patients with Primary Generalized Tonic-Clonic Seizures
12/10/2004 - 12/09/2005 (PI)
GlaxoSmithKline, Inc.

A Double-Blind, Randomized, Multicenter, Placebo-Controlled, In-Patient, Maximum 34 Day Study of Levetiracetam Oral Solution (20-50 mg/kg/day) as Adjunctive Treatment of Refractory Partial Onset Seizures in Pediatric Epileptic Subjects Ranging in Age from
10/13/2004 - 10/12/2005 (PI)
UCB Pharma, Inc.

A Multi-Center, Double-Blind, Randomized, Parallel-Group Evaluation of Lamictal Extended-Release Adjunctive Therapy In Subjects With Partial Seizures
09/27/2004 - 09/26/2005 (PI)
GlaxoSmithKline, Inc.

An Open-Label Extension Trial to Determine Tolerability and Efficacy of Long-Term Oral SPM 927 as Adjunctive Therapy in Patients with Partial Seizures
11/01/2003 - 10/31/2004 (PI)
Schwarz Biosciences, Inc.

Showing 10 of 13 results. Show All Results

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray…
02/03/2016 - 02/28/2017 (PI)
Acorda Therapeutics, INC



Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Piña-Garza JE, Montouris GD, Vekeman F, Cheng WY, Tuttle E, Giguere-Duval P, Duh MS, Shen V, Saurer TB, Isojarvi J. Assessment of treatment patterns and healthcare costs associated with probable Lennox-Gastaut syndrome. Epilepsy Behav. 2017 Aug; 73:46-50. PMID: 28609734.
  2. Gidal BE, Wechsler RT, Sankar R, Montouris GD, White HS, Cloyd JC, Kane MC, Peng G, Tworek DM, Shen V, Isojarvi J. Deconstructing tolerance with clobazam: Post hoc analyses from an open-label extension study. Neurology. 2016 Oct 25; 87(17):1806-1812. PMID: 27683846.
  3. Piña-Garza JE, Chung S, Montouris GD, Radtke RA, Resnick T, Wechsler RT. Challenges in identifying Lennox-Gastaut syndrome in adults: A case series illustrating its changing nature. Epilepsy Behav Case Rep. 2016; 5:38-43. PMID: 26977407; DOI: 10.1016/j.ebcr.2016.01.004;.
  4. Montouris G, Hohler AD. Cultural Barriers to Medication Adherence in Epilepsy. Continuum (Minneap Minn). 2016 Feb; 22(1 Epilepsy):266-9.View Related Profiles. PMID: 26844742; DOI: 10.1212/CON.0000000000000286;.
  5. Deck GM, Nadkarni N, Montouris GD, Lovett A. Congenital malformations in infants exposed to antiepileptic medications in utero at Boston Medical Center from 2003 to 2010. Epilepsy Behav. 2015 Oct; 51:166-9. PMID: 26283306; DOI: 10.1016/j.yebeh.2015.07.001;.
  6. Montouris G, Yang H, Williams B, Zhou S, Laurenza A, Fain R. Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel. Epilepsy Res. 2015 Aug; 114:131-40. PMID: 26088896; DOI: 10.1016/j.eplepsyres.2015.04.011;.
  7. Wong LC, Freeburg JD, Montouris GD, Hohler AD. Two patients with Hashimoto''s encephalopathy and uncontrolled diabetes successfully treated with levetiracetam. J Neurol Sci. 2015 Jan 15; 348(1-2):251-2.View Related Profiles. PMID: 25467138; DOI: 10.1016/j.jns.2014.11.007;.
  8. Montouris GD, Wheless JW, Glauser TA. The efficacy and tolerability of pharmacologic treatment options for Lennox-Gastaut syndrome. Epilepsia. 2014 Sep; 55 Suppl 4:10-20. PMID: 25284033; DOI: 10.1111/epi.12732;.
  9. Spengler DC, Montouris GD, Hohler AD. Levetiracetam as a possible contributor to acute kidney injury. Clin Ther. 2014 Aug 1; 36(8):1303-6.View Related Profiles. PMID: 24986483; DOI: 10.1016/j.clinthera.2014.06.002;.
  10. Karakis I, Cole AJ, Montouris GD, San Luciano M, Meador KJ, Piperidou C. Caregiver burden in epilepsy: determinants and impact. Epilepsy Res Treat. 2014; 2014:808421. PMID: 24808956; DOI: 10.1155/2014/808421;.
Showing 10 of 59 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 58 publications over 20 distinct years, with a maximum of 7 publications in 2004

YearPublications
19952
19961
19996
20006
20013
20021
20032
20047
20053
20074
20082
20091
20102
20113
20121
20134
20144
20152
20163
20171

Available to Mentor as: (Review Mentor Role Definitions):
  • Project Mentor
Contact for Mentoring:


75 E. Newton St Collamore Building
Boston MA 02118
Google Map


Montouris's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department